5-Aminolevulinic Acid-Based Photodynamic Therapy Pretreatment Mitigates Ultraviolet A-Induced Oxidative Photodamage

Area of Science:

• Dermatology
• Photobiology
• Molecular Biology

Background:

• Ultraviolet A (UVA) radiation causes significant oxidative photodamage to skin.
• Oxidative stress in skin cells contributes to aging and disease.
• Photodynamic therapy offers a potential therapeutic approach.

Purpose of the Study:

• To evaluate the efficacy of 5-aminolevulinic acid-based photodynamic therapy (ALA-PDT) against UVA-induced oxidative damage.
• To investigate ALA-PDT's effects on human epidermal keratinocytes in vitro and hairless mouse skin in vivo.

Main Methods:

• In vitro: HaCaT cells treated with ALA-PDT and exposed to UVA, measuring reactive oxygen species (ROS), superoxide (O₂^-), mitochondrial membrane potential (MMP), apoptosis, and DNA damage marker 8-oxo-dG.
• In vitro: Western blot analysis for p53, OGG1, XPC, SOD1, and SOD2.
• In vivo: Hairless mice skin treated with ALA-PDT or saline-PDT, exposed to UVA, and assessed for 8-oxo-dG.

Main Results:

• ALA-PDT pretreatment significantly reduced UVA-induced ROS, O₂^-, and apoptosis in keratinocytes.
• ALA-PDT modulated the expression of key proteins involved in DNA repair and oxidative stress response (p53, OGG1, XPC, SOD1, SOD2).
• In vivo studies confirmed that ALA-PDT pretreatment effectively prevented UVA-induced 8-oxo-dG formation in mouse skin.

Conclusions:

• 5-aminolevulinic acid-based photodynamic therapy is a potent strategy for preventing UVA-induced oxidative photodamage.
• ALA-PDT demonstrates protective effects on both cellular and in vivo skin models against UV radiation.
• This therapy holds promise for mitigating UV-related skin damage.